Results for “ ”

Entry Author Date Location
Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More 06/24/16 National
As Macchiarini Faces Charges, Biostage Forges Ahead With New Tech 06/23/16 Boston
IBM Watson Health Launches Imaging Effort for Cancer, Other Diseases 06/22/16 Boston
Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case 06/22/16 Boston
Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases 06/22/16 Boston
Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial 06/21/16 National
Sean Parker To Fund CRISPR Trial, And Other Gene Edit Milestones 06/20/16 National
See Boston’s Newest Innovators & Influencers this Wed. at INFLUX 06/20/16 Boston
Epizyme Touts Early Data From Key Trial Of Blood Cancer Drug 06/19/16 Boston
Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More 06/17/16 National
Paratek Shares Climb After Antibiotic Clears First Phase 3 Hurdle 06/16/16 Boston
Struggling Aegerion, QLT to Merge, Change Name to Novelion 06/15/16 Boston
Infinity Closes Research Ops as Blood Cancer Drug Comes Up Short 06/14/16 Boston
Eleven Bio, Still Breathing, Sells Eye Drug to Roche 06/13/16 Boston
Anemia Ups and Downs: Agios Hit On One Drug, Touts Data For Another 06/11/16 Boston
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More 06/10/16 National
Alexandria Sets up Incubator, $25M Seed Fund For NY Bio Startups 06/08/16 New York
Harvard Unveils $15M Life Lab to House Biotech and Medical Startups 06/08/16 Boston
Ginkgo Gulps $100M to Build Synthetic Food, Fragrance Business 06/08/16 Boston
Boston-Israel Connection Rising: 200-Plus Firms, 9K Jobs, $9B Sales 06/08/16 Boston
Pivoting Again, Catabasis Looks to NASH After Cholesterol Drug Flops 06/07/16 Boston
Biogen’s Nerve Repair Drug Fails MS Study, Shares Fall 06/07/16 Boston
Pronutria Rebrands as Axcella Health, Forms “Nutrition” Subsidiary 06/07/16 Boston
Startups: Get Free Tickets to Influx on June 22, Thanks to NEVCA 06/06/16 Boston
Ocular’s Shares Fall After Eye Treatment Fails Latest Test 06/06/16 Boston
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials 06/06/16 Boston
No PhD, “No Fear”: Alice Zhang, 27, Aims Software At Neuro Diseases 06/06/16 San Francisco
Vedanta Nabs $50M To Expand Microbiome Into Immune-Boosting Therapies 06/06/16 Boston
Guardant Health Maps Cautious Plans For Blood-Based Cancer Screening 06/03/16 San Francisco
Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes 06/03/16 National
Page 1 of 285 next page »